Leak Risk Tied To Endologix Grafts Found In More Models, FDA Says
A recent warning from the US agency ties two additional models of AFX endovascular grafts from Endologix Inc. to potentially fatal blood leaks. An earlier model of the devices, which are used to treat abdominal aortic aneurysms, was removed from the market last year over similar concerns.
You may also be interested in...
US FDA says that previously identified elevated risks of type III endoleaks from endovascular aneurysm repair systems appears to be linked to a specific, no-longer-sold device, Endogix's AFX with Strata system.
Through a draft guidance, the US agency has established performance criteria for magnetic resonance coils, making the devices eligible for the standards-based Safety and Performance Based Pathway.
Increasing savvy around cybersecurity issues is driving regulators and trade groups to update their approach to the area, speakers from the US FDA and the American Medical Association said at this week’s FDA/CMS Summit.